Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q4 2020 Results - Earnings Call Transcript

Moderna, Inc. (NASDAQ:MRNA) Q4 2020 Earnings Conference Call February 25, 2021 8:00 AM ET

Company Participants

Lavina Talukdar - SVP & Head, IR
Stéphane Bancel - CEO & Director
David Meline - CFO & Principal Accounting Officer
Stephen Hoge - President
Tal Zaks - Chief Medical Officer

Conference Call Participants

Matthew Harrison - Morgan Stanley
Edward Tenthoff - Piper Sandler & Co.
Salveen Richter - Goldman Sachs Group
Michael Yee - Jefferies
Huidong Wang - Barclays Bank
Cory Kasimov - JPMorgan Chase & Co.
Geoffrey Meacham - Bank of America Merrill Lynch
Hartaj Singh - Oppenheimer
Mani Foroohar - SVB Leerink
Simon Baker - Redburn

Operator

Good morning, and welcome to Moderna's Fourth Quarter 2020 Conference Call. [Operator Instructions].

At this time, I would like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar

Thank you, operator. Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's fourth quarter and full year 2020 financial results and business update. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website. On today's call are Stéphane Bancel, our CEO; David Meline, our CFO; Stephen Hoge, our President; and Tal Zaks, our Chief Medical Officer.

Before we begin, please note that this conference call will include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see Slide 2 of the accompanying presentation and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to update or revise the information provided on this call as a